Sign In
Buy AUPH
$15.67
+0.280 (+1.82%)
At Close: Jun 03, 2026
Aurinia Submits FDA New Drug Admission For Novel Voclosporin Kidney Treatment
12:16pm, Tuesday, 26'th May 2020
Shares in Aurinia Pharmaceuticals, Inc (AUPH) advanced in pre-market trading as the biotech company announced the submission of the New Drug Application (NDA) for its experimental voclosporin drug for
Aurinia Completes Submission Of New Drug Application To FDA For Voclosporin For The Treatment Of Lupus Nephritis
10:06am, Tuesday, 26'th May 2020
Aurinia Pharmaceuticals Inc. (Nasdaq:AUPH / TSX:AUP) ("Aurinia" or the "Company"), a late-stage clinical biopharmaceutical company focused on advancing voclosporin across multiple indications, today a
Billionaire Jim Simons Pulls the Trigger on These 3 Healthcare Stocks
02:04pm, Wednesday, 20'th May 2020
Despite COVID-19's devastating impact, one legendary stock picker might have just cracked the market code. While the broader market tumbled, investing firm Renaissance Technologies and its founder Jim
Aurinia Pharmaceuticals Inc (AUPH) Q1 2020 Earnings Call Transcript
08:26pm, Tuesday, 19'th May 2020
AUPH earnings call for the period ending March 31, 2020.
Aurinia Pharmaceuticals Inc. (TSE:AUP) Released Earnings Last Week And Analysts Lifted Their Price Target To US$32.00
10:10am, Tuesday, 19'th May 2020
Shareholders might have noticed that Aurinia Pharmaceuticals Inc. (TSE:AUP) filed its first-quarter result this time...
Aurinia Pharmaceuticals to Present at 2020 RBC Capital Markets’ Virtual Global Healthcare Conference
08:05pm, Friday, 15'th May 2020
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the "Company") today announced that Peter Greenleaf, President and Chief Executive Officer of Aurinia, will participate in a fireside chat durin
HealthCor Management, L.P. Buys Encompass Health Corp, ACADIA Pharmaceuticals Inc, Haemonetics ...
12:00am, Friday, 15'th May 2020Aurinia Pharmaceuticals (AUPH) Reports Q1 Loss, Misses Revenue Estimates
09:35pm, Thursday, 14'th May 2020
Aurinia (AUPH) delivered earnings and revenue surprises of 25.00% and -50.00%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Aurinia Pharmaceuticals Q1 EPS $(0.150), Inline, Sales $30.000K Miss $50.000K Estimate
08:06pm, Thursday, 14'th May 2020Aurinia Reports First Quarter 2020 Financial Results and Recent Operational Highlights
08:02pm, Thursday, 14'th May 2020
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX:AUP) ("Aurinia" or the "Company") today reported financial results for the first quarter ended March 31, 2020 and provided an update on recent operatio
Burrage Capital Management LLC Buys Cytokinetics Inc, Regenxbio Inc, Avrobio Inc, Sells Arqule ...
12:00am, Thursday, 14'th May 2020Aurinia Pharmaceuticals to Release First Quarter 2020 Financial Results on May 14, 2020
10:05am, Thursday, 07'th May 2020
Aurinia to Report 1Q20 Results on May 14, 2020
Analysts Estimate Aurinia Pharmaceuticals (AUPH) to Report a Decline in Earnings: What to Look Out for
04:30pm, Tuesday, 05'th May 2020
Aurinia (AUPH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
